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Propolis is a chemically complex resinous bee product which has gained worldwide popularity as a means to improve health
condition and prevent diseases. The main constituents of an aqueous extract of a sample of green propolis from Southeast
Brazil were shown by high performance liquid chromatography/mass spectroscopy/mass spectroscopy to be mono- and di-O-
caﬀeoylquinic acids; phenylpropanoids known as important constituents of alcohol extracts of green propolis, such as artepillin
C and drupanin were also detected in low amounts in the aqueous extract. The anti-inflammatory activity of this extract was
evaluated by determination of wound healing parameters. Female Swiss mice were implanted subcutaneously with polyesther-
polyurethane sponge discs to induce wound healing responses, and administered orally with green propolis (500 mg kg−1). At 4, 7
and 14 days post-implantation, the fibrovascular stroma and deposition of extracellular matrix were evaluated by histopathologic
and morphometric analyses. In the propolis-treated group at Days 4 and 7 the inflammatory process in the sponge was reduced in
comparison with control. A progressive increase in cell influx and collagen deposition was observed in control and propolis-treated
groups during the whole period. However, these eﬀects were attenuated in the propolis-treated group at Days 4 and 7, indicating
that key factors of the wound healing process are modulated by propolis constituents.
1. Introduction
Propolis is a resinous substance that honeybees produce by
mixing their own waxes with resins collected from plants.
It is used as a sealant and antimicrobial agent in honeybee
nests and has been used as a folk medicine since ancient
times. More recently, propolis has been found to have a
wide range of biological activities, such as, antimicrobial [1],
anti-inflammatory [2], antioxidant [3], hepatoprotective [4],
antitumor activities and, in the treatment of dermal lesions
such as burns, wounds and ulcers [5–7].
Propolis contains more than 200 constituents, including
benzoic acids [8], flavonoids [9, 10] and cinnamic acid
derivatives [11]. Depending on the location of production,
propolis has a wide variety of botanical origins and the
chemical composition varies accordingly. Thus, while caﬀeic
acid phenethyl ester (CAPE) and flavonoids are characteristic
constituents of Poplar type propolis [12], the typical con-
stituents of Brazilian green propolis derived from Baccharis
dracunculifolia are caﬀeoylquinic and prenylated cinnamic
acids, such as artepillin C and baccharin [13, 14]. Other
Brazilian green propolis are chemically diﬀerent; besides
prenylated cinnamic acids, they contain triterpenoids [11,
15, 16].
Propolis ethanol extracts (PEE) are most commonly
studied in propolis research. In contrast, propolis water
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extracts (WEP) have rarely been investigated, even though
WEP and their main constituents (including caﬀeoylquinic
acids) have higher antioxidant eﬀects, inhibitory activity
against some enzymes and absorbency than PEE and their
constituents [15]. The constituents of WEP are mainly
grouped into two classes, namely, caﬀeoylquinic acid deriva-
tives (chlorogenic acid, 3,4-di-O-caﬀeoylquinic acid and
3,5-di-O-caﬀeoylquinic acid) and cinnamic acid derivatives
(p-coumaric acid, baccharin, drupanin and artepillin C)
[17], both classes having been shown to exert a variety of
biological actions, such as anti-microbial, anti-tumor [5] and
antioxidant [2], apoptosis-inducer and immunomodulator
properties [6].
Normal wound healing is characterized by inflamma-
tory cell recruitment to the site of injury, invasion of
capillary sprouts to the fibrin clot and extracellular matrix
components deposition. Several in vivo models have been
used to characterize various components and mechanisms
involved in wound repair and also to assess the eﬀects
of potential therapeutic compounds to minimize/improve
injury adverse eﬀects. In one such model, the sponge
implant, host responses to the synthetic matrix are analogous
to the healing process, a complex series of events driven
primarily by inflammatory cells that accumulate within the
implant compartment. This is followed by angiogenesis and
extracellular matrix deposition at the site of injury. The
sponge implant model also provides a chronically inflamed
environment in which several components of the prolifer-
ative fibrovascular tissue (angiogenesis, inflammatory cells
recruitment/activation, extracellular matrix deposition) can
be determined [18–20].
The present study reports the main constituents of an
aqueous extract of Brazilian green propolis from Minas
Gerais (Southeast Brazil) and the eﬀects of the orally admin-
istered aqueous extract on distinct phases of wound healing
(cellular recruitment and extracellular matrix deposition) in
a murine sponge model.
2. Methods
2.1. Preparation of the Aqueous Extract of Green Propolis.
Propolis sample was collected in the period of September
2005 to September 2006 in the municipality of Jaguarac¸u,
Minas Gerais, Brazil from Apis mellifera hives. Samples were
homogenized and frozen at −18◦C and an aliquot (200 g)
was powdered and 500 mL of distilled water added. The
suspension was maintained for 30–60 min under stirring at
70◦C and then cooled at room temperature. The supernatant
was filtered through Whatman 1 filter paper to obtain the
first extract. The residue was treated again according to the
same procedure, with which a second extract was obtained.
The two extracts were pooled and then lyophilized.
2.2. Analysis of Chemical Composition Using HPLC/DAD/ESI/
MS/MS. The lyophilized extract was treated with
MeOH:H2O (1:1, v/v) at the concentration 1 mg mL−1
and filtered through a 0.45-μm filter (German Sciences,
Tokyo, Japan). The solution (10 μL) was injected into a
DAD SPD-M10AVP SHIMADZU High Pressure Liquid
Chromatography (HPLC) system coupled to an ESQUIRE
3000 PLUS, BRUKER DALTONICS mass spectrometer via
an electrospray ionization (ESI) source. Spectral UV data
from all peaks were accumulated in the range 240–400 nm
and chromatograms were recorded at 270 and 340 nm for
detection of phenolic compounds. The instrument was
controlled by a computer running SCL-10A VP. The mobile
phases consisted of eluent A (0.1% aq. HOAc) and eluent
B (MeOH) using a reverse phase C18 Zorbax-5B-RP-18
column (4.6 × 250 mm, 5 μm) (Hewlett Packard). A linear
gradient of 20%–90% of B (v/v) in the A/B mix was used
for analysis, according to the following gradient: 0 min,
20%; 10 min 30%; 20 min, 50%; 30 min, 70%; 40 min, 90%;
45 min, 40%; 50 min, return to the initial condition (20%)
to re-equilibrate the column prior to another run. The flow
rate was kept constant at 0.5 mL min−1 the temperature of
the column 28◦C. The ionization conditions were adjusted
as follows: ESI was achieved using an ion source voltage of
−40 V and a capillary oﬀset voltage of 4500 V. Nebulization
was aided with a coaxial nitrogen sheath gas provided at a
pressure of 27 psi. Desolvation was assisted using a counter
current nitrogen flow set at a flux of 7.0 L min−1 and capillary
temperature of 325◦C. The flux of LC/MS was 100 μL min−1.
ESI/mass spectrometry (MS) parameters, such as nature and
flow rate of the sheath liquid, nebulizer pressure, drying
gas flow rate and temperature were optimized. MS data
were obtained in the positive and negative ion modes. The
full scan mass acquisition was performed by scanning from
m/z 100–900. Collision-induced fragmentation experiments
were performed in the ion trap using He as collision
gas, with voltage ramping cycles from 0.3 up to 2 V. The
compounds were identified by comparison of their UV and
ESI/MS/MS spectra with literature data [21–23]. Relative
amounts of constituents in these extracts were assumed
to be proportional to the areas under the corresponding
chromatogram peaks.
2.3. Animals. The 90 female Swiss mice, aged 8 weeks (20–
30 g body weight) from the Animal Facility at University
Federal of Minas Gerais (UFMG) used in this study were
maintained in the animal house of the Department of
General Pathology of the Institute of Biological Sciences.
2.4. Preparation of the Sponge Discs and Implantation.
Polyester-polyurethane sponge discs with 5 mm thickness,
8 mm diameter and weighing 4.6 mg (Vitaform Ltd, Manch-
ester, UK) were used as the matrix for fibrovascular tissue
growth. The sponge discs were soaked overnight in a 70% v/v
ethanol solution and sterilized by boiling in distilled water
for 15 min before the implantation surgery. The animals were
anesthetized with a mixture of (10 mg kg−1) xylazine and
(100 mg kg−1) ketamine hydrochloride (i.p.). Their dorsal
hair was shaved and the skin wiped with 70% ethanol.
Sponge discs were aseptically implanted into a subcutaneous
pouch that had been made with curved artery forceps
through a 1 cm long dorsal mid-line incision. After sponge
implantation, the animals were maintained in individual
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Table 1: Chromatographic and spectroscopic data of constituents of an aqueous extract of a sample of Brazilian green propolis from Minas
Gerais (Southeast Brazil), obtained by HPLC/ESI/MS
Peak
Retention
time (min)
Relative
amount
(%)
UV (nm) [M + H]+ m/z [M−H]− m/z Proposed identification
1 14.4 1.2 ND 355.2 353.4 3-O-(E)-caﬀeoylquinic acid
2 17.6 4.4 300 sh, 330 355.2 353.1 5-O-(E)-caﬀeoylquinic acid
3 20.9 2.6 300 sh, 330 355.2 353.1 4-O-(E)-caﬀeoylquinic acid
4 27.1 13.8 300 sh, 330 521.4 519.2 Didihydrocaﬀeoylquinic acid
5 29.0 15.8 300 sh, 330 517.3 515.2 3,4-Di-O-(E)-caﬀeoylquinic acid
6 31.5 8.0 300 sh, 330 517.3 515.2 3,5-Di-O-(E)-caﬀeoylquinic acid
7 32.5 27.2 330 ND 515.2 4,5-Di-O-(E)-caﬀeoylquinic acid
8 41.3 2.0 315 ND 231.2 4-Hydroxy-3-prenyl-cinnamic acid (drupanin)
9 47.0 5.0 315 ND 299.5 4-Hydroxy-3,5-diprenyl-cinnamic acid (artepilin C)
ND: not determined.
cages and provided with chow pellets and water ad libitum.
The light/dark cycle was 12:12 h with lights on at 7:00 am and
lights oﬀ at 7:00 pm.
Housing and anesthesia concurred with the guidelines
established by our local Institutional Animal Welfare Com-
mittee (number 161/05).
The treated group (n = 8–10) for each time point received
propolis orally by gavage (500 mg kg−1) daily from the day
of implantation and the control group (n = 8–10) received
saline in the same schedule. At fixed time intervals (4, 7 and
14 days post-implantation) the mice were killed by cervical
dislocation and the sponge discs carefully removed, dissected
free from the adherent tissue, weighed and processed for
histological assessment.
2.5. Histology. The sponge implants were carefully collected,
fixed in formalin (10% in isotonic saline), embedded in
paraﬃn, and 5 μm-thick sections were obtained. The sections
were stained with hematoxylin and eosin for determina-
tion of the fibrovascular tissue infiltration and examined
under a light microscope. Picrosirius-red staining followed
by polarized-light microscopy was used to visualize and
determine collagen fibers [24].
2.6. Morphometric Analysis of the Fibrovascular Area and
Collagen Deposition. Microscopic images of cross-sections
(5 μm) were obtained with a planapochromatic objective
×40 (400x) in light microscopy. The images were digitized
through a JVC TK-1270/JGB microcamera and transferred
to an image analyzer (Kontron Eletronics, Carl Zeiss—KS300
version 2). In order to quantify the fibrovascular area and
the deposition of collagen fibers 15 fields were obtained
with a planapochromatic objective 10x (100x) for each cross-
section and then analyzed morphometrically.
2.7. Statistical Analysis. Results are presented as mean ±
SEM. Comparisons between two groups ( n = 8–10 per
group) of mice were carried out using Student’s t-test for
unpaired data. A P-value < .05 was considered significant.
Statistical analysis was performed using Graph-Pad Prism
4.01.
3. Results
3.1. Chemical Analyses. As shown in Table 1, the major
constituents of the aqueous extract of the propolis sample
analyzed are caﬀeoylquinic acids: 4,5-di-O-caﬀeoylquinic
(27.2%), 3,4-di-O-(E)-caﬀeoylquinic (15.8%), didihydrocaf-
feoylquinic (13.8%) and 3,5-di-O-(E)-caﬀeoylquinic (8.0%).
Other caﬀeoylquinic acids, such as 4-O-(E)-caﬀeoylquinic
acid, 5-O-(E)-caﬀeoylquinic acid and cinnamic acid deriva-
tives, such as artepillin C and drupanin are minor con-
stituents (2.6, 4.4, 5.0 and 2.0%, resp., Table 1).
Peaks 1, 2 and 3, with retention times (RT) 14.4, 17.6 and
20.9, respectively, Table 1, presented m/z 353 in the negative
mode, complying with the molecular formula C16H18O9.
The corresponding UV spectra are characteristic of caf-
feoylquinic acid derivatives (UV ≈ 298 and 325 nm). The
relative intensities of ions in each spectrum of these chloro-
genic acid isomers were significantly diﬀerent using the same
MS/MS condition. MS/MS of 5-O-(E)-caﬀeoylquinic acid
was dominated by a single peak m/z 191, while MS/MS of 4-
O-(E)-caﬀeoylquinic acid was dominated by m/z 173 as base
peak (100) and, in addition, showed fragments at m/z 179
(50) and 191 (60). MS/MS of 3-O-(E)-caﬀeoylquinic acid
was dominated by m/z 191 as base peak, accompanied by a
fragment at m/z 179 (60). Esters of caﬀeic with quinic acid
at positions 3, 4 and 5 are also known as neochlorogenic,
cryptochlorogenic and chlorogenic acid, respectively.
Peaks 5, 6 and 7 (RT 29.0, 31.5 and 32.5, resp., Table 1)
showed UV spectra identical with the caﬀeoylquinic acids
described above. Their measured masses were in agreement
with masses of protonated ([M + H]+) and deproto-
nated ([M−H]−) di-O-(E)-caﬀeoylquinic acids, 517.3 and
515.2, respectively, Table 1. The data suggest identity with
positional isomers of di-O-(E)-caﬀeoylquinic acid, with
molecular formula C25H24O12 and molecular weight 516.0.
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Figure 1: Representative histological sections of sponge implants (5 μm stained with HE) from control (a, c, and e) and propolis-treated
groups (b, d, and f) at 4, 7 and 14 days, respectively. The fibrovascular stroma that occupies the pores of the sponge matrix (s) is progressively
filled with inflammatory cells, blood vessels (v), fibroblasts and collagen fibers. The granulation tissue in control implants is denser and more
vascularized compared with the propolis-treated group. Arrowheads indicate the cell infiltration in the implant (a, b). Inset (1000x): A—
arrows show inflammatory cells infiltration; C—arrow shows giant cell and (v) shows blood vessel; E—arrow heads and (v) in the inset
(1000x) show blood vessel; F—arrow head shows blood vessel. Bar: 16 μm.
Peaks 5 and 6 were tentatively identified as 3,4-di-O-(E)-
caﬀeoylquinic and 3,5-di-O-(E)-caﬀeoylquinic acid, respec-
tively. As to peak 7, a proposal is put forward that it cor-
responds to 4,5-di-O-(E)-caﬀeoylquinic acid. Base peak of
MS/MS spectra of compounds 5–7 is m/z 353, which derives
from loss of one caﬀeoyl fragment; it is thus consistent
with the assignment as caﬀeoylcaﬀeoyl quinic acids. MS/MS
of 3,4-di-O-(E)-caﬀeoylquinic acid (peak 5, Table 1) was
dominated by m/z 353 (100) and contained fragments at m/z
191 (30), 179 (60) and 173 (25); MS/MS of 3,5-di-O-(E)-
caﬀeoylquinic acid (peak 6, Table 1) was dominated by m/z
353 (100) and contained fragments at m/z 191 (45), 179 (40)
and 173 (20), while MS/MS of 4,5-di-O-(E)-caﬀeoylquinic
acid (peak 7, Table 1) was dominated by m/z 353 (100) and
contained fragments at m/z 191 (20), 179 (20) and 173 (20).
Peak 4 was tentatively identified as a didihydrocaf-
feoylquinic acid derivative. Its UV spectrum is identical
with spectra of caﬀeoylquinic acids. The compound showed
[M−H]− at m/z 519.2 and [M + H]+ at m/z 521.4, consistent
with molecular formula C25H28O12 and molecular mass
520.0, which corresponds to 4 Da above molecular masses
of di-O-(E)-caﬀeoylquinic acids.
Peaks 8 and 9 have UV spectra characteristic of cinnamic
acid derivatives (315 nm) and [M−H]− at m/z 231.2 and
299.5, respectively, consistent with the known green propolis
constituents drupanin and artepillin C, respectively.
3.2. Histological Assessments. The sponge matrix was well
tolerated by all animals. No sign of infection or rejection
was observed in the implant compartment during the 14-
day period of the experiment. Systemic administration of
propolis (500 mg kg−1) during the experimental period (4–
14 days) showed no signs of toxicity such as weight loss,
sedation, or alterations in motor activity of the animals.
Subcutaneous implantation of sponge discs in mice
induced a progressive wound repair response causing the
synthetic matrix to be filled with fibrovascular stroma. After
HE staining, sponge implants of both groups presented
fibrovascular tissue at the three time points studied. The
histological changes during the development of the newly
formed tissue are illustrated in Figures 1(a)–1(f). At Day
4, the implants in the control group showed much more
inflammatory cells accumulation compared with the treated
group. Also, in comparison to the treated group, by Day 7
and 14, the sponge in the control group was much more
vascularized and contained many more inflammatory cells,
multinucleated giant cells and fibroblasts interspersed within
the granulation tissue.
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Figure 2: Wet weight (a) and fibrovascular area (b) of the implants from control and propolis-treated groups are shown in this Figure. In
the treated group the wet weight was significantly lower than in the control group at day 7. The fibrovascular area in the propolis-treated
group was significantly reduced compared with the control group at days 4 and 7. Data are represented as mean ± SEM of groups of 8–10
animals. ∗P < .05 compared with control group.
3.3. Tissue Infiltration and Collagen Deposition. Tissue infil-
tration and extracellular matrix deposition of the implants
were assessed quantitatively from the wet weight of the
sponges and morphometric analysis of HE staining sections.
The wet weight of the control implants was significantly
higher than the treated implants by day 7 (Figure 2(a). The
morphometric area (μm2) occupied by the fibrovascular tis-
sue grew throughout the 14-day period postimplantation in
both types of implants. However, the fibrovascular area in the
control group was bigger compared with the treated group
(Figure 2(b)). Both parameters therefore, corroborated the
histological assessment (Figures 1(c) and 1(d)). In addition,
we investigated the kinetics of collagen deposition during
the whole period of sponge implantation as determined by
densitometric analysis of implants stained with Picrosirius-
red (Figures 3(a)–3(f)). The results clearly show a progressive
increase of this extracellular matrix component and an
inhibitory eﬀect of propolis in both thin and dense collagen
at all time points (Figures 4(a) and 4(b)).
4. Discussion
In this study we determined the chemical composition of a
water extract of Brazilian green propolis from Minas Gerais,
Brazil [11] and evaluated the systemic eﬀects of this extract
in healing parameters in a sponge model. Although propolis
is reputed as an anti-inflammatory agent and used to heal a
variety of lesions including sores, ulcers and skin incisions
[25], its eﬀects on distinct phases of healing processes
(cellular recruitment, proliferation and remodeling) has not
been evaluated simultaneously in deep skin injury.
Chlorogenic acids are a family of esters containing quinic
acid and certain trans-cinnamic acids, most commonly caf-
feic, p-coumaric and ferulic. The residues of trans-cinnamic
acids can be attached at one or more hydroxyls at positions
1, 3, 4 and 5 of quinic acid, originating a series of positional
isomers. These compounds predominate in the aqueous
extract analyzed and thus are probably the constituents
accounting for the observed wound healing eﬀects. Although
extensively studied for many years, precise identification
of these compounds in plant extracts is diﬃcult due
to the lack of commercial standards and the constraints
of distinguishing reliably among positional isomers when
multiple forms are present at low concentrations and inter-
conversion of isomers is possible during workup [26]. Mono-
and di-caﬀeoylquinic acids have been reported as salient
compounds of aqueous extracts of Brazilian propolis [13].
The Asteraceae family, which includes B. dracunculifolia
(source of green propolis resin), is known to be particularly
diverse as to the contents of chlorogenic acids. Some but
not all of its species are able to esterify all four quinic acid
hydroxyls, not just with several cinnamic acids, but also with
succinic acid [26].
The implantation technique induced the formation of a
fibrovascular stroma that occupied the pores of the sponge
matrix with inflammatory cells, blood vessels, fibroblasts and
collagen fibers. The granulation tissue in control implants
was denser and more vascularized compared with the
propolis-treated group. This was reflected in the wet weight
of the implants that were lighter in the treated group. Further
corroboration of this finding was given by the size of the
fibrovascular area that was increased ∼3-fold in the control
group compared with the treated group at Days 4 and 7 post
implantation. Our results are in line with the work by others
that using diﬀerent healing models showed decreased cellular
recruitment after the treatment with propolis [2, 27–29].
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Figure 3: Representative histological sections of sponge implants (5 μm stained with Picrossirius-red) for collagen assessment from control
(a, c, and e) and propolis-treated (b, d, and f). The implant was progressively infiltrated by thin collagen (green area) up to 7 days in both
groups. After 14 days post implantation, the sponge matrix was predominantly occupied by dense collagen (red and yellow areas) in the
propolis-treated and control groups. The collagen area in the propolis-treated group was significantly reduced compared with the control
group at days 4, 7 and 14 (arrow heads indicate the most important areas). Bar: 16 μm.
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Figure 4: Morphometric analysis of the collagen deposition showing that the deposition of thin (a) and dense (b) collagen in the implants
was significantly lower in the treated group at 4 and 7 days post-implantation. Data are represented as mean ± SEM of groups of 8–10
animals. ∗P < .05 compared with control group.
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Figure 5: Schematic diagram representing the eﬀects of WEP
on fibrovascular tissue growth in sponge implant in mice. WEP
attenuated cellular infiltration and deposition of type III collagen,
without compromising deposition of type I collagen.
Hu et al. [29] in experiments with carragenin demonstrated
that artepilin C was able to inhibit the mobilization of neu-
trophils in the abdominal cavity. This observation was also
recently confirmed by Paulino et al. [2] and in our aqueous
extract artepilin C was also detected in a quantity which
was probably enough to exert inhibition of inflammatory cell
recruitment. It has been reported that phenolic compounds
exert a wide range of biological properties such as ability to
perform anti-oxidant activity by scavenging free radicals and
to accelerate cutaneous wound healing [17, 30, 31].
Collagen deposition is an important component of
repair. It has been demonstrated that thick fibrils consist of
type I collagen and thin, type III collagen [32]. In our exper-
iments, Picrosirius red staining showed two distinct patterns
of collagen within the sponge matrix. The deposition of this
extracellular component increased progressively from day 4
until day 14 and the fibers became thicker, changing from
green (Type III) to yellow/red (Type I) in both types of
implants. This profile of collagen deposition in the sponge
implants is consistent with previous work in our model as
well as in other types of synthetic matrices and in open and
incisional wounds [19, 33]. In the propolis-treated group,
however, the rate of collagen deposition was delayed at days 4
and 7 postimplantation but reached the levels of the control
group by day 14. It is clear that propolis was able to aﬀect
collagen type I deposition only at the early phases of the
repair process. Probably, attenuation of cell recruitment by
propolis has accelerated the proliferative phase of the repair
process promoting rapid transformation of type III collagen
on type I collagen. Further investigation will be addressed
in future experiments to clarify this issue. Our results are
in contrast with those by Kilicoglu et al. [34] that showed
accelerated healing of colon anastomosis following systemic
administration of propolis. One possible explanation for
this discrepancy may be due to the intrinsic nature of the
tissues evaluated. Another possibility is related with specio-
geographic variation of propolis known to determine its
chemical composition and biological activities. In addition,
the extraction methods (aqueous or ethanolic) constitute
another source of variability. Nevertheless, our results show
that although propolis has suppressed an important inflam-
matory component (cell influx) the deposition of collagen
at day 14 was not aﬀected by the compound, confirming and
expanding the relationship between excess inflammation and
aberrant scarring [35]. Thus, our study suggests that aqueous
extract of Brazilian green propolis might be used to control
the inflammatory response without compromising the repair
process as proposed in the hypothetical diagram (Figure 5).
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